Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.

Details

Ressource 1Download: 37415560.pdf (775.19 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_ECDD80B202C8
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.
Journal
Journal of the European Academy of Dermatology and Venereology
Author(s)
Armstrong A., Eyerich K., Conrad C., Zhu Y., Yang Y.W., Miller M., You Y., Shen Y.K., Foley P., Griffiths CEM, Strober B.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
12/2023
Peer-reviewed
Oui
Volume
37
Number
12
Pages
e1375-e1379
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Keywords
Humans, Antibodies, Monoclonal, Humanized/therapeutic use, Adalimumab, Psoriasis/drug therapy, Severity of Illness Index, Treatment Outcome, Double-Blind Method
URN
urn:nbn:ch:serval-BIB_ECDD80B202C83
OAI-PMH
oai:serval.unil.ch:BIB_ECDD80B202C8
DOI
10.1111/jdv.19309
Pubmed
37415560
Web of science
001038661400001
Open Access
Yes
Create date
10/07/2023 13:49
Last modification date
13/12/2023 7:26
Usage data